Paclitaxel-loaded ginsenoside Rg3 liposomes for drug-resistant cancer therapy by dual targeting of the tumor microenvironment and cancer cells

INTRODUCTION: Inherent or acquired resistance to paclitaxel (PTX) is a pivotal challenge for chemotherapy treatment of multidrug-resistant (MDR) breast cancer. Although various targeted drug-delivery systems, including nanoparticles and liposomes, are effective for MDR cancer treatment, their effica...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Ying, Wang, Anni, Zhang, Shuya, Kim, Jisu, Xia, Jiaxuan, Zhang, Fengxue, Wang, Dan, Wang, Qi, Wang, Jianxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334248/
https://www.ncbi.nlm.nih.gov/pubmed/36167294
http://dx.doi.org/10.1016/j.jare.2022.09.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334248/
https://www.ncbi.nlm.nih.gov/pubmed/36167294
http://dx.doi.org/10.1016/j.jare.2022.09.007

Ejemplares similares